These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L; Eymin B; Brambilla E; Gazzeri S Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784 [TBL] [Abstract][Full Text] [Related]
23. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004 [TBL] [Abstract][Full Text] [Related]
24. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Warner BJ; Blain SW; Seoane J; Massagué J Mol Cell Biol; 1999 Sep; 19(9):5913-22. PubMed ID: 10454538 [TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor. Tsubari M; Tiihonen E; Laiho M Cancer Res; 1997 Jul; 57(14):2966-73. PubMed ID: 9230210 [TBL] [Abstract][Full Text] [Related]
26. Identification of JTP-70902, a p15(INK4b)-inductive compound, as a novel MEK1/2 inhibitor. Yamaguchi T; Yoshida T; Kurachi R; Kakegawa J; Hori Y; Nanayama T; Hayakawa K; Abe H; Takagi K; Matsuzaki Y; Koyama M; Yogosawa S; Sowa Y; Yamori T; Tajima N; Sakai T Cancer Sci; 2007 Nov; 98(11):1809-16. PubMed ID: 17784872 [TBL] [Abstract][Full Text] [Related]
27. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
28. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Wen-Sheng W Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382 [TBL] [Abstract][Full Text] [Related]
29. INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform. Tian X; Azpurua J; Ke Z; Augereau A; Zhang ZD; Vijg J; Gladyshev VN; Gorbunova V; Seluanov A Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1053-8. PubMed ID: 25550505 [TBL] [Abstract][Full Text] [Related]
30. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Shintani S; Nakahara Y; Mihara M; Ueyama Y; Matsumura T Oral Oncol; 2001 Sep; 37(6):498-504. PubMed ID: 11435176 [TBL] [Abstract][Full Text] [Related]
31. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence. Shin J; Yang J; Lee JC; Baek KH Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963 [TBL] [Abstract][Full Text] [Related]
32. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633 [TBL] [Abstract][Full Text] [Related]
33. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Parry D; Mahony D; Wills K; Lees E Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865 [TBL] [Abstract][Full Text] [Related]
34. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression. Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969 [TBL] [Abstract][Full Text] [Related]
35. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. Feng XH; Lin X; Derynck R EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220 [TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839 [TBL] [Abstract][Full Text] [Related]
37. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547 [TBL] [Abstract][Full Text] [Related]
38. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Reynisdóttir I; Massagué J Genes Dev; 1997 Feb; 11(4):492-503. PubMed ID: 9042862 [TBL] [Abstract][Full Text] [Related]
39. Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia. Maloney KW; McGavran L; Odom LF; Hunger SP Blood; 1999 Apr; 93(7):2380-5. PubMed ID: 10090949 [TBL] [Abstract][Full Text] [Related]
40. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]